Accelerate to discover

Back to filter

Related topics

Discover the advanced Detector Technology in Agilent NovoCyte flow cytometers

Agilent technologies

Nov 8, 2021

This technical overview describes advancements in detector technology, and highlights examples where optimal signal...

Introducing isoLight system - Automated Cellular Proteomics hub

IsoPlexis

Nov 4, 2021

The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...

Introducing Cytek NEW 25-Color Immunoprofiling Assay & Kit!

Cytek Biosciences

Oct 25, 2021

To unleash the power of the Cytek full spectrum cytometry system, Cytek scientists designed and developed the 25-Color...

Curiox webinar: Laminar Wash enables single-cell multiomics and cell hashing

Curiox

Oct 11, 2021

Professor Mats Bemark’s lab at the University of Gothenburg in Sweden studies how the immune system responds to...

Dec 1, 2021

IncuCyte Cell-by-Cell : advancing label-free morphological analysis

Sartorius & Essen BioScience

Sep 29, 2021

Cell morphology reveals valuable insight into cell health and status, and considerable heterogeneity exists in even the...

Deep-Learning, Label-Free, Quantitative Cell Segmentation with IncuCyte

Sartorius & Essen BioScience

Sep 24, 2021

Sartorius Unveils LIVECell, a Deep-Learning Dataset for Label-Free, Quantitative Cell Segmentation in Nature Methods.

Meet ACCELA at International Conference Analytical Cytometry 2021

Cytek Biosciences

Sep 23, 2021

Meet us at International Conference Analytical Cytometry 2021. ACCELA will be present as...

Dec 1, 2021

See What's Possible with the PippinHT

Sage Science

Sep 14, 2021

Programmable DNA size selection enables new discoveries by helping optimize the library detected by a sequencer. That’s...

Show all topics (10)

IsoPlexis technology: accelerating decisions in immunotherapy with predictive single-cell response

Nov 25, 2021

The IsoLight platform’s predictive single-cell response enables quality assessments of T cell immunotherapies, as well as improved assessment of clinical response and mechanism of action in patient samples.Toxicity, low or no response, and relapse are major challenges of immune-based cancer therapies faced on both manufacturing and clinical development pathways toward success in patient outcome. Confounding factors with respect to specifications for toxicity and potentially lethal side effects in chimeric antigen receptor (CAR) T cell therapies are related to the complex functional responses of these engineered T cells. Isoplexis provides actionable potency, safety, and patient-difference metrics by assessing deep T cell functional response in patients, accelerating decisions toward clinical success downstream, and enhancing scalability

Learn more, read the full paper

Technical breakthrough
Product news

Related technologies: Functional biology

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

IsoPlexis

Systems, which drive convergence of dynamic proteomics and single cell biology for the first time, are creating this deeper connection to accelerate curative medicines.

Related products

The hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell chip and software products

show detail

A personalized functional proteomics system for every lab

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey